Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 1693-1699

  Anantharaman, Aparna ^a   Rizvi, Meryam Sardar ^b   Sahal, Dinkar ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; ALPHA,BETA DIDEHYDROPHENYLALANINE; DELTA FM PROTEIN; DELTA FMSCR PROTEIN; DELTA FQ PROTEIN; DENDRIMER; KANAMYCIN; LYSINE; PHENYLALANINE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; UD PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG SELECTIVITY; ESCHERICHIA COLI; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; KINETICS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG DESIGN; DRUG SYNERGISM; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FIBROBLASTS; HELA CELLS; HUMANS; KANAMYCIN; MICE; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACID SYNTHESIS INHIBITORS; RIFAMPIN;

EID: 77951251397     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01231-09     Document Type: Article

References (32)

1. Ahmad, A., S. P. Yadav, N. Asthana, K. Mitra, S. P. Srivastava, and J. K. Ghosh. 2006. Utilization of an amphipathic leucine zipper sequence to design antibacterial peptides with simultaneous modulation of toxic activity against human red blood cells. J. Biol. Chem. 281:22029-22038.
2. Asthana, N., S. P. Yadav, and J. K. Ghosh. 2004. Dissection of antibacterial and toxic activity of melittin. J. Biol. Chem. 279:55042-55050.
3. Barriere, S. L. 1992. Bacterial resistance to beta-lactams and its prevention with combination antimicrobial therapy. Pharmacotherapy 12:397-402.
4. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
5. Bulet, P., R. Stocklin, and L. Menin. 2004. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198:169-184.
6. Chu-Kung, A. F., K. N. Bozzelli, N. A. Lockwood, J. R. Haseman, K. H. Mayo, and M. V. Tirrell. 2004. Promotion of peptide antimicrobial activity by fatty acid conjugation. Bioconjug. Chem. 15:530-535.
7. Cottagnoud, P., M. Cottagnoud, and M. G. Täuber. 2003. Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin. Antimicrob. Agents Chemother. 47:144-147.
8. Darveau, R. P., M. D. Cunningham, C. L. Seachord, L. C. Clough, W. L. Cosand, J. Blake, and C. S. Watkins. 1991. Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob. Agents Chemother. 35:1153-1159.
9. Dathe, M., T. Wieprecht, H. Nikolenko, L. Handel, W. L. Maloy, D. L. MacDonald, D. L. Beyermann, and M. Bienert. 1997. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and hemolytic activity of amphipathic helical peptides. FEBS Lett. 403:208-212.
10. Dewan, P. C., A. Anantharaman, V. S. Chauhan, and D. Sahal. 2009. Antimicrobial action of prototypic amphipathic cationic decapeptides and their branched dimers. Biochemistry 48:5642-5657.
11. Fehri, L. F., H. Wróblewski, and A. Blanchard. 2007. Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis. Antimicrob. Agent Chemother. 51:468-474.
12. Giangaspero, A., L. Sandri, and A. Tossi. 2001. Amphipathic alpha helical antimicrobial peptides. A systematic study of the effects of structural and physical properties on biological activity. Eur. J. Biochem. 268:5589-5600.
13. Hale, J. D. F., and R. E. W. Hancock. 2007. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 5:951-959.
14. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
15. Hancock, R. E. W., and H. Sahl. 2006. Antimicrobial and host defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24: 1551-1557.
16. Juvvadi, P., S. Vunnam, and R. B. Merrifield. 1996. Synthetic melittin, its enantio, retro, and retroenantio isomers, and selected chimeric analogs: their antibacterial, hemolytic, and lipid bilayer action. J. Am. Chem. Soc. 118: 8989-8997.
17. Kaiser, E., R. L. Colescott, C. D. Bossinger, and P. I. Cook. 1970. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34:595-598.
18. Kondejewskii, L. H., M. J. Niaraki, S. W. Farmer, B. Lix, C. M. Kay, B. D. Sykes, R. E. W. Hancock, and R. S. Hodges. 1999. Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J. Biol. Chem. 274:13181-13192.
19. Makovitzki, A., D. Avrahami, and Y. Shai. 2006. Ultrashort antibacterial and antifungal lipopeptides. Proc. Natl. Acad. Sci. U. S. A. 103:15997-16002.
20. McCafferty, D. G., P. Cudic, M. K. Yu, D. C. Behenna, and R. Kruger. 1999. Synergy and duality in peptide antibiotic mechanisms. Curr. Opin. Chem. Biol. 3:672-680.
21. Park, Y., H. J. Kim, and K. Hahm. 2004. Antibacterial synergism of novel antibiotic peptides with chloramphenicol. Biochem. Biophys. Res. Commun. 321:109-115.
22. Puius, Y. A., T. H. Stievater, and T. Srikrishnan. 2006. Crystal structure, conformation and absolute configuration of kanamycin A. Carbohydr. Res. 341:2871-2875.
23. Radzishevsky, I. S., S. Rotem, D. Bourdetsky, S. Navon-Venezia, Y. Carmeli, and A. Mor. 2007. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 25:657-659.
24. Ramagopal, U. A., S. Ramakumar, D. Sahal, and V. S. Chauhan. 2001. De novo design and characterization of an apolar helical hairpin peptide at atomic resolution: compaction mediated by weak interactions. Proc. Natl. Acad. Sci. U. S. A. 98:870-874.
25. Rand, K. H., and H. J. Houck. 2004. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. J. Antimicrob. Chemother. 53:530-532.
26. Steinberg, D. A., M. A. Hurst, C. A. Fujii, A. H. C. Kung, J. F. Ho, F. C. Cheng, D. J. Loury, and J. C. Fiddes. 1997. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41:1738-1742.
27. Stratton, C. W. 2003. Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance. Emerg. Infect. Dis. 9:10-16.
28. Tenecza, S. B., D. J. Creighton, T. Yuan, H. J. Vogel, R. C. Montelaro, and T. A. Meitzner. 1999. Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerization. J. Antimicrob. Chemother. 44:33-41.
29. Wu, Y. L., E. M. Scott, A. L. W. Po, and V. N. Tariq. 1999. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 44:389-392.
30. Yan, H., and R. E. W. Hancock. 2001. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 45:1558-1560.
31. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
32. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.